|
|
|
|
John Soden, III
Managing Director
Healthcare Investment Banking
+1 415.364.5941
jsoden@tweisel.com
John Soden is a Managing Director in Healthcare Investment Banking at Thomas Weisel Partners. John joined the firm in 2004 and is based in San Francisco. He focuses on medical technologies and life science tools/reagents. He has 12 years of experience in investment banking. Prior to joining the firm, John was a Director in both the Healthcare and M&A groups at UBS Investment Bank; he joined the predecessor firm, Dillon, Read & Co. as an Associate. He began his investment banking career as a Financial Analyst focused on Energy M&A at CS First Boston. John received a BA degree in Economics with honors from Northwestern University.
|
|
Notable Transactions
ev3 Inc./FoxHollow Technologies, Inc. |
EVVV |
M&A
|
$780.0 USD
|
10/4/07
|
Symyx Technologies/MDL Information Systems |
SMMX |
M&A
|
$123.0 USD
|
10/2/07
|
Hansen Medical |
HNSN |
IPO
|
$86.3 USD
|
11/15/06
|
LeMaitre Vascular |
LMAT |
IPO
|
$38.5 USD
|
10/19/06
|
Caliper Life Sciences/Xenogen Corp. |
CALP |
M&A
|
$80.0 USD
|
8/9/06
|
American Medical Systems Holdings, Inc/Laserscope |
AMMD |
M&A
|
$715.0 USD
|
7/19/06
|
American Medical Systems Holdings |
AMMD |
CVT
|
$373.8 USD
|
6/21/06
|
Applied Biosystems Inc./Ambion |
ABI |
M&A
|
$273.0 USD
|
3/2/06
|
Vital Signs, Inc. |
VITL |
FO
|
$97.3 USD
|
2/2/06
|
NxStage Medical |
NXTM |
IPO
|
$63.3 USD
|
10/27/05
|
AtriCure |
ATRC |
IPO
|
$55.2 USD
|
8/5/05
|
ev3 Inc. |
EVVV |
IPO
|
$167.7 USD
|
6/16/05
|
Jabil Circuit Inc./Varian Inc. |
JBL |
M&A
|
$195.0 USD
|
3/11/05
|
FoxHollow Technologies |
FOXH |
IPO
|
$72.5 USD
|
10/28/04
|
|
|
